Skip to main content

All Content

Search Tips
Published Date
Original Publication Date
Original Publication Date
PSNet Publication Date
Narrow Results By
PSNet Original Content
Commonly Searched Resource Types
1 - 6 of 6
MedWatch Safety Alert. Silver Spring, MD: US Food and Drug Administration; July 30, 2015.
Look-alike and sound-alike drug names can contribute to confusion and result in medication errors. To raise awareness of potential wrong-patient errors due to similarity between two proprietary names, this announcement describes near misses with the drugs at the prescribing and dispensing stage and suggests clinicians use the generic names for the medications to reduce risk of patient harm.

Dornan T, Ashcroft D, Heathfield H, et al. London: General Medical Council; 2009.

This report analyzed the causes and rates of prescribing errors in the National Health Service and found that educational level had little impact on medication errors and that many were intercepted before reaching patients. The authors suggest that a standardized national prescription chart could help prevent errors.
Washington DC: Office of the Assistant Secretary of Defense; Tricare Management Activity: 2011.
This report series discusses activities and achievements of the U.S. Department of Defense's health care program in including culture of safety development, error and near miss report analysis, and medical team coordination. There were 5 editions of the report produced between 2005-2011.
House of Commons Committee on Public Accounts. London: The Stationery Office Limited; June 2006.
Using data from approximately 974,000 patient safety incidents and near misses reported to the National Patient Safety Agency between 2004–2005, this report summarizes trends, improvements, and areas of weakness in incident reporting.
Institute for Safe Medication Practices
The Institute for Safe Medication Practices (ISMP) administers this national reporting program, which collects confidential reports of medication errors and near misses directly from practitioners. Information is forwarded to the US Food and Drug Administration and product manufacturers. The program also provides access to ISMP's patient safety organization reporting mechanism and publishes the National Alert Network or NAN Alerts to share information generated from report analysis broadly to support learning.